Skip to main content
. 2020 Jun 14;12(6):1570. doi: 10.3390/cancers12061570

Table 1.

Sensitivity of glioblastoma (GBM) cells to Src tyrosine kinase (Src) inhibitors after 72 h treatment expressed as IC50 values (µM).

Compounds U87 1 U87-TxR 1 GBM-4 GBM-5 GBM-6
Si306 3.081 ± 0.260 4.775 ± 0.322 20.270 ± 1.225 15.250 ± 1.207 19.120 ± 1.652
Pro-Si306 3.045 ± 0.343 3.419 ± 0.359 25.390 ± 1.159 19.920 ± 1.196 18.280 ± 1.696
Dasatinib 6.143 ± 0.464 8.516 ± 0691 18.60 ± 1.259 25.610 ± 1.216 25.350 ± 1.199

1 Data taken from [28].